209 related articles for article (PubMed ID: 31926625)
1. Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1/p38-MAPK signalling pathway.
Shu N; Hägglund P; Cai H; Hawkins CL; Davies MJ
Redox Biol; 2020 Jan; 29():101400. PubMed ID: 31926625
[TBL] [Abstract][Full Text] [Related]
2. The effects of acrolein on the thioredoxin system: implications for redox-sensitive signaling.
Myers CR; Myers JM; Kufahl TD; Forbes R; Szadkowski A
Mol Nutr Food Res; 2011 Sep; 55(9):1361-74. PubMed ID: 21812108
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-mimetic peptides (TXM) reverse auranofin induced apoptosis and restore insulin secretion in insulinoma cells.
Cohen-Kutner M; Khomsky L; Trus M; Aisner Y; Niv MY; Benhar M; Atlas D
Biochem Pharmacol; 2013 Apr; 85(7):977-90. PubMed ID: 23327993
[TBL] [Abstract][Full Text] [Related]
4. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
5. Redox cycling of 1,2-naphthoquinone by thioredoxin1 through Cys32 and Cys35 causes inhibition of its catalytic activity and activation of ASK1/p38 signaling.
Shinkai Y; Iwamoto N; Miura T; Ishii T; Cho AK; Kumagai Y
Chem Res Toxicol; 2012 Jun; 25(6):1222-30. PubMed ID: 22587396
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
[TBL] [Abstract][Full Text] [Related]
7. Impaired cross-talk between the thioredoxin and glutathione systems is related to ASK-1 mediated apoptosis in neuronal cells exposed to mercury.
Branco V; Coppo L; Solá S; Lu J; Rodrigues CMP; Holmgren A; Carvalho C
Redox Biol; 2017 Oct; 13():278-287. PubMed ID: 28600984
[TBL] [Abstract][Full Text] [Related]
8. Inhibition and crosslinking of the selenoprotein thioredoxin reductase-1 by p-benzoquinone.
Shu N; Cheng Q; Arnér ESJ; Davies MJ
Redox Biol; 2020 Jan; 28():101335. PubMed ID: 31590044
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems.
Go YM; Roede JR; Walker DI; Duong DM; Seyfried NT; Orr M; Liang Y; Pennell KD; Jones DP
Mol Cell Proteomics; 2013 Nov; 12(11):3285-96. PubMed ID: 23946468
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
Fang J; Holmgren A
J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
[TBL] [Abstract][Full Text] [Related]
12. A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells.
Cheng X; Holenya P; Can S; Alborzinia H; Rubbiani R; Ott I; Wölfl S
Mol Cancer; 2014 Sep; 13():221. PubMed ID: 25253202
[TBL] [Abstract][Full Text] [Related]
13. Diarachidonoylphosphoethanolamine induces apoptosis of malignant pleural mesothelioma cells through a Trx/ASK1/p38 MAPK pathway.
Tsuchiya A; Kaku Y; Nakano T; Nishizaki T
J Pharmacol Sci; 2015 Nov; 129(3):160-8. PubMed ID: 26588871
[TBL] [Abstract][Full Text] [Related]
14. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
Montano SJ; Lu J; Gustafsson TN; Holmgren A
Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
[TBL] [Abstract][Full Text] [Related]
15. Bacterial thioredoxin and thioredoxin reductase as mediators for epigallocatechin 3-gallate-induced antimicrobial action.
Liang W; Fernandes AP; Holmgren A; Li X; Zhong L
FEBS J; 2016 Feb; 283(3):446-58. PubMed ID: 26546231
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues.
Hashemy SI; Holmgren A
J Biol Chem; 2008 Aug; 283(32):21890-8. PubMed ID: 18544525
[TBL] [Abstract][Full Text] [Related]
17. Reaction of quinones with proteins: Kinetics of adduct formation, effects on enzymatic activity and protein structure, and potential reversibility of modifications.
Shu N; Lorentzen LG; Davies MJ
Free Radic Biol Med; 2019 Jun; 137():169-180. PubMed ID: 31026584
[TBL] [Abstract][Full Text] [Related]
18. Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells.
Myers JM; Antholine WE; Myers CR
Toxicology; 2008 Apr; 246(2-3):222-33. PubMed ID: 18328613
[TBL] [Abstract][Full Text] [Related]
19. Cysteine residues mediate high-affinity binding of thioredoxin to ASK1.
Kylarova S; Kosek D; Petrvalska O; Psenakova K; Man P; Vecer J; Herman P; Obsilova V; Obsil T
FEBS J; 2016 Oct; 283(20):3821-3838. PubMed ID: 27588831
[TBL] [Abstract][Full Text] [Related]
20. Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions.
Hansen JM; Zhang H; Jones DP
Free Radic Biol Med; 2006 Jan; 40(1):138-45. PubMed ID: 16337887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
